Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Men

Erscheinungsjahr 2011
ISBN: 978-0-19-957277-9
Verlag: Oxford University Press

Buch, Englisch, 208 Seiten, Format (B × H): 102 mm x 180 mm, Gewicht: 158 g

Reihe: Oxford Urology Library

The diagnosis and treatment of benign prostatic hyperplasia (BPH) is considered to be one of the most important topics in urology and afflicts millions of older men world-wide. Although it is not life threatening, its clinical manifestation as lower urinary tract symptoms (LUTS) reduces the patient's quality of life over many years. Patients often suffer from LUTS due to BPH for a long time. If left untreated, the patients are at significant risk of potentially severe complications.

Over the last decade, new diagnostic approaches and treatment options such as prostate lasers have become more accepted in the urological community. This pocketbook provides an update of several aspects related with BPH / LUTS and covers the entire background, diagnostic process and treatment options available to patients suffering from LUTS due to BPH. It will give trainees in urology and general physicians a quick, concise but complete overview of diagnostic processes and recommended
treatment options.

Autoren/Hrsg.

Bachmann, Alexander

de la Rosette, Jean

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Urologie, Andrologie, Venerologie

Inhaltsverzeichnis

1: Definitions (LUTS, BPH, BPE, BOO, BPO)
2: Natural history of untreated BPH and its impact on LUTS
3: Pathophysiology of BPH, symptoms and symptom scores (AUA-SI, IPSS, ICIQ-MLUTS)
4: BPH, PSA and the risk of having prostate cancer (PCA)
5: Erectile Dysfunction (ED) associated with LUTS and BPH
6: Over-active bladder (OAB), LUTS and BPH - a paradigm shift
7: Bladder outflow obstruction (BOO), urodynamic studies and BPH
8: Aging men and LUTS
9: Risk factors associated with BPH
10: Diagnostic and assessment of BPH - subjective parameter
11: Diagnostic and assessment of BPH - objective parameter
12: Watchful waiting and life-style issues associated with LUTS and BPH
13: Medical treatment of LUTS and BPH
14: Interventional treatment of BPH
15: Risk adapted management of BPH

Über Autor(innen)

Edited by Alexander Bachmann, Head, Department of Urology, University of Basel, University Hospital Basel, Switzerland, and Jean de la Rosette, Chairman, Department of Urology, AMC University Hospital, The Netherlands

Prof. Dr. Alexander Bachmann was born in 1968 in Leipzig, Germany and earned his medical degree at Leipzig University Medical School in 1994. After residency in St. Gallen, Cologne, Zürich, Gelsenkirchen and Leverkusen he became a specialist in urology in 2002. Since April 2006 he has been the Head and Chairman of the Department of Urology Basel - Liestal, University Hospital Basel. Dr Bachmann specializes in the field of ablative and reconstructive laparoscopy including donor nephrectomy and is a founding member if the International Greenlight user group (IGLU). He is member of the European Association of Urology (EAU) and has written numerous peer-reviewed publications in high-ranked Journals, including European Urology, Journal of Urology, Transplantation and World Journal of Urology.

Dr de la Rosette is Professor and Chairman of the Department of Urology, at AMC University Hospital in Amsterdam, the Netherlands. He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. He was subsequently appointed consultant urologist and Director of Minimal Invasive Urology at the Department of Urology at the St Radboud University Hospital in Nijmegen. Dr de la Rosette is the chairman of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) of the International Consultation on BPH. He is also chairman of the committee on Renal Stone Disease of the International Consultation on Stone Diseases. Both consultations are patronised by the World Health Organisation (WHO). Dr de la Rosette has written over 300 peer reviewed publications and has authored many book chapters.

Contributors:
Karl-Erik Andersson, Department of Clinical Pharmacology, Lund University Hospital, Sweden
Reginald Bruskewitz, West Clinic, UW Health Urology Clinic, US
Lukas Bubendorf, Institut für Pathologie, Universitätsspital Basel, Switzerland
Thomas Gasser, Chefarzt, Urologische Klinik, Kantonsspital Liestal, Switzerland
Christian Stief, Direktor, Urologische Klinik und Poliklinik, Klinikum der Universität München - Großhadern, Germany
M. Michel, Urologische Klinik, Universitätsklinik Mannheim, Germany
Stephan Degener, Department of Urology, Klinikum Wuppertal, University Medical Center Wiiten/Herdecke, Germany
Michael J. Mathers, Urological Ambulatory Remscheid, in cooperation with the Department of Urology, Klinikum Wuppertal, University Medical Center Wiiten/Herdecke, Germany
Stavros Gravas, Department of Urology, University Hospital of Larissa, Greece
Herbert Leyh, Chefarzt der Urologie, Klinikum Garmisch-Partenkirchen GmbH, Germany
M. Oelke, Ltd. Oberarzt, Urologische Klinik, Universität Hannover, Germany
J. Nordling, Department of Urology, Herlev Hospital, University of Copenhagen, Denmark
M. C. Michel, Afd. Farmacologie and Farmacotherapie, AMC, Universiteit van Amsterdam, The Netherlands
C. Gratzke, Urologische Klinik und Poliklinik, Klinikum der Universität München - Großhadern, Germany
O. Reich, Urologische Klinik und Poliklinik, Klinikum der Universität München - Großhadern, Germany
T. Sulser, Direktor, Urologische Klinik, Universitätsspital Zürich, Switzerland
Peter J. Gilling, Promed Urology Limited, New Zealand
A. J. Gross, Chefarzt der Urologischen Abteilung der Asklepios Klinik Barmbek, Germany
M. Seitz, Urologische Klinik und Poliklinik, Klinikum der Universität München - Großhadern, Germany
Stephan Madersbacher, Stellvertretender Abteilungsvorstand der Abteilung für Urologie und Andrologie, Sozialmedizinisches Zentrum Ost Donauspital, Wien, Austria
Jens Rassweiler, Direktor Urologische Klinik, SLK-Kliniken Heilbronn, Germany
G.H. Muir, Consultant Urologist, North Downs House, UK
Stephen Wyler, Urologische Klinik, Universitätsspital Basel, Switzerland